Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?

被引：2

作者：

Golubeva, Julia A. ^{[1
]}

Sheptulina, Anna F. ^{[1
,2
]}

Elkina, Anastasia Yu. ^{[1
,3
]}

Liusina, Ekaterina O. ^{[1
]}

Kiselev, Anton R. ^{[4
]}

Drapkina, Oxana M. ^{[1
,2
]}

机构：

[1] Natl Med Res Ctr Therapy & Prevent Med, Dept Fundamental & Appl Aspects Obes, Moscow 101990, Russia

[2] AI Evdokimov Moscow State Univ Med & Dent, Dept Therapy & Prevent Med, Moscow 127473, Russia

[3] Saratov State Med Univ, Dept Intermediate Level Therapy, Saratov 410012, Russia

[4] Natl Med Res Ctr Therapy & Prevent Med, Coordinating Ctr Fundamental Res, Moscow 101990, Russia

来源：

BIOMEDICINES | 2023年 / 11卷 / 09期

基金：

俄罗斯科学基金会;

关键词：

non-alcoholic fatty liver disease; hypertension; steatohepatitis; BLOOD-PRESSURE; INSULIN-RESISTANCE; INCIDENT HYPERTENSION; METABOLIC SYNDROME; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; FETUIN-A; ASSOCIATION; STEATOHEPATITIS;

D O I：

10.3390/biomedicines11092465

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.

引用

页数：25

共 50 条

[1] Carotid atherosclerosis or nonalcoholic fatty liver disease: Which comes first?
Dogru, Teoman
Genc, Halil
Ercin, Cemal Nuri
[J]. ATHEROSCLEROSIS, 2013, 231 (02) : 187 - 188
[2] Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first?
Ahmed, Mohamed H.
Ali, Asif
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (05) : 521 - 527
[3] Diabetes mellitus and fatty liver disease: Which comes first?
Alavian, Seyed Moayed
[J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2010, 8 (03) : 130 - 131
[4] Which treatment for nonalcoholic fatty liver disease?
Moscatiello, S.
Marzocchi, R.
Villanova, N.
Bugianesi, E.
Marchesini, G.
[J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (08) : 767 - 775
[5] Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension
Zhao, Yan-Ci
Zhao, Guo-Jun
Chen, Ze
She, Zhi-Gang
Cai, Jingjing
Li, Hongliang
[J]. HYPERTENSION, 2020, 75 (02) : 275 - 284
[6] Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease
Baffy, Gyorgy
[J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 563 - 576
[7] Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease
Gyorgy Baffy
[J]. Digestive Diseases and Sciences, 2018, 63 : 563 - 576
[8] The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?
Spengler, Erin
Loomba, Rohit
[J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2015, 1 (02): : 129 - 130
[9] Prevalence and treatment of arterial hypertension among patients with biopsy proven nonalcoholic fatty liver disease
Steffen, H. -M.
Schulte, S.
Lengerli, K.
Rodmanis, C.
Demir, M.
Goeser, T.
[J]. JOURNAL OF HYPERTENSION, 2008, 26 : S102 - S102
[10] The Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease
Yong-Jae Lee
Jae-Yong Shim
Byung-Soo Moon
Youn-Ho Shin
Dong-Hyuk Jung
Jung-Hyun Lee
Hye-Ree Lee
[J]. Digestive Diseases and Sciences, 2012, 57 : 196 - 203

← 1 2 3 4 5 →